136 related articles for article (PubMed ID: 17456611)
1. Complications arising from intravenous buprenorphine abuse.
Seet RC; Oh VM; Lim EC
QJM; 2007 May; 100(5):312-3. PubMed ID: 17456611
[No Abstract] [Full Text] [Related]
2. Precipitated withdrawal in an opioid-dependent outpatient receiving alternate-day buprenorphine dosing.
Jacobs EA; Bickel WK
Addiction; 1999 Jan; 94(1):140-1. PubMed ID: 10665107
[No Abstract] [Full Text] [Related]
3. The use of sublingual buprenorphine-naloxone for reversing heroin overdose: a high-risk strategy that should not be recommended.
Nielsen S; Lintzeris N
Addiction; 2008 Dec; 103(12):2065-6. PubMed ID: 19469751
[No Abstract] [Full Text] [Related]
4. Neonatal outcome of 58 infants exposed to maternal buprenorphine in utero.
Hytinantti T; Kahila H; Renlund M; Järvenpää AL; Halmesmäki E; Kivitie-Kallio S
Acta Paediatr; 2008 Aug; 97(8):1040-4. PubMed ID: 18474065
[TBL] [Abstract][Full Text] [Related]
5. Intravenous use of buprenorphine tablets associated with rhabdomyolysis and compressive sciatic neuropathy.
Seet RC; Lim EC
Ann Emerg Med; 2006 Apr; 47(4):396-7. PubMed ID: 16546629
[No Abstract] [Full Text] [Related]
6. [Severe distal ischemic syndrome after buprenorphine volunteer intra-arterial injection].
Glaizal M; Lucciardi J; Tichadou L; Spadari M; Hayek-Lanthois M; Micallef J; de Haro L
Therapie; 2011; 66(6):545-7. PubMed ID: 22186079
[TBL] [Abstract][Full Text] [Related]
7. The clinical efficacy and abuse potential of combination buprenorphine-naloxone in the treatment of opioid dependence.
Mammen K; Bell J
Expert Opin Pharmacother; 2009 Oct; 10(15):2537-44. PubMed ID: 19708849
[TBL] [Abstract][Full Text] [Related]
8. An integrated program of buprenorphine in the primary care setting for HIV(+) persons in Rhode Island.
Mitty J; Macleod C; Loewenthal H; Thompson L; Bazerman L
Med Health R I; 2007 May; 90(5):145-7. PubMed ID: 17557657
[No Abstract] [Full Text] [Related]
9. Drugs approved for opiate dependence.
FDA Consum; 2003; 37(1):6. PubMed ID: 12625293
[No Abstract] [Full Text] [Related]
10. UNUSUAL OVERDOSE.
Faber B; Barr J
JEMS; 2015 Sep; 40(9):22-3. PubMed ID: 26554176
[No Abstract] [Full Text] [Related]
11. Buprenorphine for depression: the un-adoptable orphan.
Callaway E
Biol Psychiatry; 1996 Jun; 39(12):989-90. PubMed ID: 8780832
[No Abstract] [Full Text] [Related]
12. [Opiate replacement therapy in France: assessment of the public policies].
Chast F
Ann Pharm Fr; 2009 Sep; 67(5):299-303. PubMed ID: 19695365
[No Abstract] [Full Text] [Related]
13. Abuse liability of buprenorphine-naloxone tablets in untreated IV drug users.
Alho H; Sinclair D; Vuori E; Holopainen A
Drug Alcohol Depend; 2007 Apr; 88(1):75-8. PubMed ID: 17055191
[TBL] [Abstract][Full Text] [Related]
14. Puffy hand syndrome due to drug addiction: a case-control study of the pathogenesis.
Andresz V; Marcantoni N; Binder F; Velten M; Alt M; Weber JC; Stephan D
Addiction; 2006 Sep; 101(9):1347-51. PubMed ID: 16911735
[TBL] [Abstract][Full Text] [Related]
15. Buprenorphine: a safe agent for opioid dependent patients who are under the increased risk of stroke?
Yulug B; Ozan E
J Opioid Manag; 2009; 5(3):134. PubMed ID: 19662922
[No Abstract] [Full Text] [Related]
16. Comparative treatment and mortality correlates and adverse event profile of implant naltrexone and sublingual buprenorphine.
Reece AS
J Subst Abuse Treat; 2009 Oct; 37(3):256-65. PubMed ID: 19394789
[TBL] [Abstract][Full Text] [Related]
17. Multifocal bone infarcts and buprenorphine: association or coincidence?
Laroche M; Brouchet A; Mazières B
J Rheumatol; 2009 Oct; 36(10):2369-70. PubMed ID: 19820227
[No Abstract] [Full Text] [Related]
18. Patients' help-seeking behaviours for health problems associated with methadone and buprenorphine treatment.
Winstock AR; Lea T; Sheridan J
Drug Alcohol Rev; 2008 Jul; 27(4):393-7. PubMed ID: 18584389
[TBL] [Abstract][Full Text] [Related]
19. Cutaneous complications among i.v. buprenorphine users.
Ho RC; Ho EC; Mak A
J Dermatol; 2009 Jan; 36(1):22-9. PubMed ID: 19207433
[TBL] [Abstract][Full Text] [Related]
20. Buprenorphine-induced elevated liver enzymes in an adolescent patient.
Upadhyay A; Xueming Y
J Child Adolesc Psychopharmacol; 2010 Dec; 20(6):545-6. PubMed ID: 21186976
[No Abstract] [Full Text] [Related]
[Next] [New Search]
